Reader View AI Reader View FDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugs www.investing.com · November 9, 2026 · 16:36 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link